5Jui Y T, Wlofe M S, Xai W. The search for γ-Secretase and devel- opment of inhibitors [J]. Curr Med Chem, 2002, 9 ( 11 ): 1087.
6Kallijarvi J, Haltia M, Baumann M H. Amphoterin includes ase- quence motif which is homologous to the Alzheimer's beta amyloid peptide (A beta), forms amyloid fibrils in vitro, and binds avidly to A beta [J]. Biochemistry, 2001, 40(34) :10032.
7Lndmark K. Could intake of vitamins C and E inhibit development of Alzheimer dementia [J]. Tidsskr Nor Laegeforen, 2006, 126 ( 2 ): 159.
8Tanzi R E, Moir R D, Wagner S L. Clearance of Alzheimer' s Abeta peptide: the many roads to perdition[J]. Neuron, 2004, 43(5 ): 605.
9Gong Y, Chang L, Viola K L, et al. Alzheimer's disease affected brain: presence of oligomric A beta ligands (ADDIS) suggests a molecular basis for reversible memory loss [J]. Proc Natl Acad Sci USA, 2003, 100( 18):10417.
10Soto C, Castano E M. The conformation of Alzheimer s betapeptide determines the rate of amyloid formation and its resistance to prote- olysis[J]. Biochem J, 1996, 314(Pt2 ): 701.
